In colorectal cancer, the RNA N+6-methyladenosine (m6A) program can regulate C1Q+ TAMs, which express multiple immunomodulatory ligands to modulate tumor-infiltrating CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.